KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Labcorp Holdings (LH) Cash & Equivalents (2016 - 2026)

Labcorp Holdings' Cash & Equivalents history spans 18 years, with the latest figure at $981.1 million for Q1 2026.

  • On a quarterly basis, Cash & Equivalents rose 165.59% to $981.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was $981.1 million, a 165.59% increase, with the full-year FY2025 number at $532.3 million, down 64.95% from a year prior.
  • Cash & Equivalents hit $981.1 million in Q1 2026 for Labcorp Holdings, up from $532.3 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for LH hit a ceiling of $1.9 billion in Q2 2023 and a floor of $99.3 million in Q1 2024.
  • Historically, Cash & Equivalents has averaged $773.6 million across 5 years, with a median of $598.1 million in 2025.
  • Biggest five-year swings in Cash & Equivalents: plummeted 86.27% in 2024 and later skyrocketed 272.0% in 2025.
  • Tracing LH's Cash & Equivalents over 5 years: stood at $320.6 million in 2022, then skyrocketed by 67.44% to $536.8 million in 2023, then soared by 182.92% to $1.5 billion in 2024, then tumbled by 64.95% to $532.3 million in 2025, then soared by 84.31% to $981.1 million in 2026.
  • Business Quant data shows Cash & Equivalents for LH at $981.1 million in Q1 2026, $532.3 million in Q4 2025, and $598.1 million in Q3 2025.